How to buy INVO Bioscience (INVO.US) stock | finder.com

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy INVO Bioscience stock

Own INVO Bioscience stock in just a few minutes.

INVO Bioscience, Inc is a medical devices business based in the US. INVO Bioscience shares (INVO) are listed on the NASDAQ and all prices are listed in US Dollars. INVO Bioscience employs 5 staff and has a trailing 12-month revenue of around USD$1.2 million.

How to buy shares in INVO Bioscience

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for INVO Bioscience. Find the stock by name or ticker symbol: INVO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until INVO Bioscience reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of INVO Bioscience, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of INVO Bioscience. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

INVO Bioscience share price

Use our graph to track the performance of INVO stocks over time.

INVO Bioscience shares at a glance

Information last updated 2021-03-22.
52-week rangeUSD$2.8 - USD$8
50-day moving average USD$4.0614
200-day moving average USD$3.8473
Wall St. target priceUSD$5.88
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy INVO Bioscience shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy INVO Bioscience stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

INVO Bioscience financials

Revenue TTM USD$1.2 million
Gross profit TTM USD$1.3 million
Return on assets TTM -128.54%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation USD$43.9 million

TTM: trailing 12 months

Shorting INVO Bioscience shares

There are currently 16,770 INVO Bioscience shares held short by investors – that's known as INVO Bioscience's "short interest". This figure is 15.6% down from 19,865 last month.

There are a few different ways that this level of interest in shorting INVO Bioscience shares can be evaluated.

INVO Bioscience's "short interest ratio" (SIR)

INVO Bioscience's "short interest ratio" (SIR) is the quantity of INVO Bioscience shares currently shorted divided by the average quantity of INVO Bioscience shares traded daily (recently around 129000). INVO Bioscience's SIR currently stands at 0.13. In other words for every 100,000 INVO Bioscience shares traded daily on the market, roughly 130 shares are currently held short.

To gain some more context, you can compare INVO Bioscience's short interest ratio against those of similar companies.

However INVO Bioscience's short interest can also be evaluated against the total number of INVO Bioscience shares, or, against the total number of tradable INVO Bioscience shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case INVO Bioscience's short interest could be expressed as 0% of the outstanding shares (for every 100,000 INVO Bioscience shares in existence, roughly 0 shares are currently held short) or 0.0018% of the tradable shares (for every 100,000 tradable INVO Bioscience shares, roughly 2 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against INVO Bioscience.

Find out more about how you can short INVO Bioscience stock.

INVO Bioscience share dividends

We're not expecting INVO Bioscience to pay a dividend over the next 12 months.

You may also wish to consider:

Have INVO Bioscience's shares ever split?

INVO Bioscience's shares were split on a 5:8 basis on 8 November 2020. So if you had owned 8 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your INVO Bioscience shares – just the quantity. However, indirectly, the new 60% higher share price could have impacted the market appetite for INVO Bioscience shares which in turn could have impacted INVO Bioscience's share price.

INVO Bioscience share price volatility

Over the last 12 months, INVO Bioscience's shares have ranged in value from as little as $2.8 up to $8. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while INVO Bioscience's is -1.3288. This would suggest that INVO Bioscience's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, INVO Bioscience has bucked the trend.

To put INVO Bioscience's beta into context you can compare it against those of similar companies.

INVO Bioscience overview

INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. The company offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development; and INVOcell Retention device, a single-use modified diaphragm that includes holes to allow for natural drainage of vaginal fluids to aid in retention of the INVOcell device in the vaginal cavity during the incubation period. It also provides fixed laboratory equipment comprising microscopes with video systems, bench centrifuges, incubators without CO2, bench warmers, and laminar flow hoods. The company sells its products to physicians and IVF centers. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Massachusetts.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site